← Back

$ Value

$0

Shares

8,100

Price

$0

Filed

Jun 25

Insider

Name

Gregoire Sylvie

Title

CIK

0001335822

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-06-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,100

Footnotes

On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date.

Filing Info

Accession No.

0001437749-25-021269

Form Type

4

Issuer CIK

0001053691

Gregoire Sylvie's History

Date Ticker Type Value
2026-02-11 CRVO A $0
2025-11-17 CRVO $91K
2025-11-17 CRVO $91K
2025-11-14 CRVO $13K
2025-11-14 CRVO $13K
2025-11-13 CRVO $33K
2025-11-12 CRVO $41K
2025-06-23 CRVO A $0

Other Insiders at CRVO (90d)

Insider Bought Sold Last
ALAM JOHN J
CEO & President
2026-02-11
Gregoire Sylvie 2026-02-11
Blackburn Kelly
EVP, Clinical Development
2026-02-11
ELDER WILLIAM ROBERT
CFO, GC & Secretary
2026-02-11
De Rosch Mark
EVP, RA and GA and PgM
2026-02-11
Winton Matthew
Chief Commercial and Business
2026-02-11